GIGA-564

GIGA-564 · GigaGen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GIGA-564, covering 2025-04-10 to 2025-04-10. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation and Expansion Study of GIGA-564 in Participants With Locally Advanced or Metastatic Solid Tumor Malignancies [Phase 1]

See pricing